APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanomedicine Manufacturing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nanomedicine Manufacturing Services Market Analysis and Forecast 2026-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchNanomedicine Manufacturing Services Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanomedicine Manufacturing Services Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nanomedicine Manufacturing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanomedicine Manufacturing Services Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanomedicine Manufacturing Services Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Nanomedicine Manufacturing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nanomedicine Manufacturing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nanomedicine Manufacturing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nanomedicine Manufacturing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nanomedicine Manufacturing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nanomedicine Manufacturing Services include nanoComposix, Ardena Nanomedicines, Cytiva, Inside Therapeutics, Fortis Life Sciences, AstraZeneca, Ascendia Pharmaceuticals, Axolabs and AVANSA Technology & Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nanomedicine Manufacturing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nanomedicine Manufacturing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanomedicine Manufacturing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanomedicine Manufacturing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanomedicine Manufacturing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanomedicine Manufacturing Services revenue, projected growth trends, production technology, application and end-user industry.

Nanomedicine Manufacturing Services Segment by Company

nanoComposix

Ardena Nanomedicines

Cytiva

Inside Therapeutics

Fortis Life Sciences

AstraZeneca

Ascendia Pharmaceuticals

Axolabs

AVANSA Technology & Services

MyBiotech

Nanochemazone

TechNanoIndia

Encapsula NanoSciences

STA Pharmaceutical Co. Ltd.

Nanomedicine Manufacturing Services Segment by Type

Nanocarrier Construction

Drug Production

Quality Testing

Process Development

Nanomedicine Manufacturing Services Segment by Application

Cancer

Cardiovascular Disease

Nervous System Disease

Infectious Disease

Others

Nanomedicine Manufacturing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanomedicine Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanomedicine Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanomedicine Manufacturing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nanomedicine Manufacturing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nanomedicine Manufacturing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanomedicine Manufacturing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanomedicine Manufacturing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nanocarrier Construction Major Player Table 3. Drug Production Major Player Table 4. Quality Testing Major Player Table 5. Process Development Major Player Table 6. Global Nanomedicine Manufacturing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Cancer Major Player Table 8. Cardiovascular Disease Major Player Table 9. Nervous System Disease Major Player Table 10. Infectious Disease Major Player Table 11. Others Major Player Table 12. Nanomedicine Manufacturing Services Industry Trends Table 13. Nanomedicine Manufacturing Services Industry Drivers Table 14. Nanomedicine Manufacturing Services Industry Opportunities and Challenges Table 15. Nanomedicine Manufacturing Services Industry Restraints Table 16. Global Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Nanomedicine Manufacturing Services Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Nanomedicine Manufacturing Services Market Share by Region (2021-2026) Table 19. Global Nanomedicine Manufacturing Services Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Nanomedicine Manufacturing Services Market Share by Region (2027-2032) Table 21. Global Nanomedicine Manufacturing Services Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Nanomedicine Manufacturing Services Revenue Market Share by Players (2021-2026) Table 23. Global Nanomedicine Manufacturing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Nanomedicine Manufacturing Services Key Players Headquarters & Area Served Table 25. Global Nanomedicine Manufacturing Services Players, Product Type & Application Table 26. Global Nanomedicine Manufacturing Services Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Nanomedicine Manufacturing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Nanomedicine Manufacturing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Nanomedicine Manufacturing Services Revenue Market Share by Type (2021-2026) Table 33. Global Nanomedicine Manufacturing Services Revenue Market Share by Type (2027-2032) Table 34. Global Nanomedicine Manufacturing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Nanomedicine Manufacturing Services Revenue Market Share by Application (2021-2026) Table 38. Global Nanomedicine Manufacturing Services Revenue Market Share by Application (2027-2032) Table 39. nanoComposix Company Information Table 40. nanoComposix Business Overview Table 41. nanoComposix Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. nanoComposix Nanomedicine Manufacturing Services Product Portfolio Table 43. nanoComposix Recent Development Table 44. Ardena Nanomedicines Company Information Table 45. Ardena Nanomedicines Business Overview Table 46. Ardena Nanomedicines Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio Table 48. Ardena Nanomedicines Recent Development Table 49. Cytiva Company Information Table 50. Cytiva Business Overview Table 51. Cytiva Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Cytiva Nanomedicine Manufacturing Services Product Portfolio Table 53. Cytiva Recent Development Table 54. Inside Therapeutics Company Information Table 55. Inside Therapeutics Business Overview Table 56. Inside Therapeutics Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio Table 58. Inside Therapeutics Recent Development Table 59. Fortis Life Sciences Company Information Table 60. Fortis Life Sciences Business Overview Table 61. Fortis Life Sciences Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio Table 63. Fortis Life Sciences Recent Development Table 64. AstraZeneca Company Information Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AstraZeneca Nanomedicine Manufacturing Services Product Portfolio Table 68. AstraZeneca Recent Development Table 69. Ascendia Pharmaceuticals Company Information Table 70. Ascendia Pharmaceuticals Business Overview Table 71. Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio Table 73. Ascendia Pharmaceuticals Recent Development Table 74. Axolabs Company Information Table 75. Axolabs Business Overview Table 76. Axolabs Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Axolabs Nanomedicine Manufacturing Services Product Portfolio Table 78. Axolabs Recent Development Table 79. AVANSA Technology & Services Company Information Table 80. AVANSA Technology & Services Business Overview Table 81. AVANSA Technology & Services Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio Table 83. AVANSA Technology & Services Recent Development Table 84. MyBiotech Company Information Table 85. MyBiotech Business Overview Table 86. MyBiotech Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. MyBiotech Nanomedicine Manufacturing Services Product Portfolio Table 88. MyBiotech Recent Development Table 89. Nanochemazone Company Information Table 90. Nanochemazone Business Overview Table 91. Nanochemazone Nanomedicine Manufacturing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Nanochemazone Nanomedicine Manufacturing Services Product Portfolio Table 93. Nanochemazone Recent Development Table 94. TechNanoIndia Company Information Table 95. TechNanoIndia Business Overview Table 96. TechNanoIndia Nanomedicine Manufacturing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio Table 98. TechNanoIndia Recent Development Table 99. Encapsula NanoSciences Company Information Table 100. Encapsula NanoSciences Business Overview Table 101. Encapsula NanoSciences Nanomedicine Manufacturing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio Table 103. Encapsula NanoSciences Recent Development Table 104. STA Pharmaceutical Co. Ltd. Company Information Table 105. STA Pharmaceutical Co. Ltd. Business Overview Table 106. STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio Table 108. STA Pharmaceutical Co. Ltd. Recent Development Table 109. North America Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Nanomedicine Manufacturing Services Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Nanomedicine Manufacturing Services Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Nanomedicine Manufacturing Services Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Nanomedicine Manufacturing Services Revenue by Country (US$ Million) & (2027-2032) Table 123. China Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 124. China Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 125. China Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 126. China Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Nanomedicine Manufacturing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Nanomedicine Manufacturing Services Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Nanomedicine Manufacturing Services Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Nanomedicine Manufacturing Services Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Nanomedicine Manufacturing Services Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Nanomedicine Manufacturing Services Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Nanomedicine Manufacturing Services Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Nanomedicine Manufacturing Services Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Nanomedicine Manufacturing Services Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Nanomedicine Manufacturing Services Image Figure 2. Global Nanomedicine Manufacturing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanomedicine Manufacturing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nanocarrier Construction Image Figure 5. Drug Production Image Figure 6. Quality Testing Image Figure 7. Process Development Image Figure 8. Global Nanomedicine Manufacturing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nanomedicine Manufacturing Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Cancer Image Figure 11. Cardiovascular Disease Image Figure 12. Nervous System Disease Image Figure 13. Infectious Disease Image Figure 14. Others Image Figure 15. Global Nanomedicine Manufacturing Services Market Size (US$ Million) & (2021-2032) Figure 16. Global Nanomedicine Manufacturing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Nanomedicine Manufacturing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Nanomedicine Manufacturing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nanomedicine Manufacturing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nanomedicine Manufacturing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nanomedicine Manufacturing Services Revenue Market Share by Type (2021-2032) Figure 23. Global Nanomedicine Manufacturing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nanomedicine Manufacturing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Nanomedicine Manufacturing Services Revenue Market Share by Application (2021-2032) Figure 26. North America Nanomedicine Manufacturing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032) Figure 28. North America Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032) Figure 29. North America Nanomedicine Manufacturing Services Revenue Share by Country (2021-2032) Figure 30. United States Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Nanomedicine Manufacturing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032) Figure 35. Europe Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032) Figure 36. Europe Nanomedicine Manufacturing Services Revenue Share by Country (2021-2032) Figure 37. Germany Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Nanomedicine Manufacturing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032) Figure 47. China Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032) Figure 48. Asia Nanomedicine Manufacturing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032) Figure 50. Asia Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032) Figure 51. Asia Nanomedicine Manufacturing Services Revenue Share by Region (2021-2032) Figure 52. Japan Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Nanomedicine Manufacturing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032) Figure 60. SAMEA Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032) Figure 61. SAMEA Nanomedicine Manufacturing Services Revenue Share by Country (2021-2032) Figure 62. Brazil Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Nanomedicine Manufacturing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nanocarrier Construction
  • Drug Production
  • Quality Testing
  • Process Development
Applications
  • Cancer
  • Cardiovascular Disease
  • Nervous System Disease
  • Infectious Disease
  • Others
Companies covered
  • nanoComposix
  • Ardena Nanomedicines
  • Cytiva
  • Inside Therapeutics
  • Fortis Life Sciences
  • AstraZeneca
  • Ascendia Pharmaceuticals
  • Axolabs
  • AVANSA Technology & Services
  • MyBiotech
  • Nanochemazone
  • TechNanoIndia
  • Encapsula NanoSciences
  • STA Pharmaceutical Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nanomedicine Manufacturing Services Market by Type
  3. 1.2.1 Global Nanomedicine Manufacturing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nanocarrier Construction
  5. 1.2.3 Drug Production
  6. 1.2.4 Quality Testing
  7. 1.2.5 Process Development
  8. 1.3 Nanomedicine Manufacturing Services Market by Application
  9. 1.3.1 Global Nanomedicine Manufacturing Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Cancer
  11. 1.3.3 Cardiovascular Disease
  12. 1.3.4 Nervous System Disease
  13. 1.3.5 Infectious Disease
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Nanomedicine Manufacturing Services Market Dynamics
  1. 2.1 Nanomedicine Manufacturing Services Industry Trends
  2. 2.2 Nanomedicine Manufacturing Services Industry Drivers
  3. 2.3 Nanomedicine Manufacturing Services Industry Opportunities and Challenges
  4. 2.4 Nanomedicine Manufacturing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nanomedicine Manufacturing Services Market Perspective (2021-2032)
  2. 3.2 Global Nanomedicine Manufacturing Services Growth Trends by Region
  3. 3.2.1 Global Nanomedicine Manufacturing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nanomedicine Manufacturing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Nanomedicine Manufacturing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nanomedicine Manufacturing Services Revenue by Players
  2. 4.1.1 Global Nanomedicine Manufacturing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Nanomedicine Manufacturing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nanomedicine Manufacturing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nanomedicine Manufacturing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nanomedicine Manufacturing Services Key Players Headquarters & Area Served
  7. 4.4 Global Nanomedicine Manufacturing Services Players, Product Type & Application
  8. 4.5 Global Nanomedicine Manufacturing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nanomedicine Manufacturing Services Market CR5 and HHI
  11. 4.6.3 2025 Nanomedicine Manufacturing Services Tier 1, Tier 2, and Tier 3
5 Nanomedicine Manufacturing Services Market Size by Type
  1. 5.1 Global Nanomedicine Manufacturing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 5.3 Global Nanomedicine Manufacturing Services Revenue Market Share by Type (2021-2032)
6 Nanomedicine Manufacturing Services Market Size by Application
  1. 6.1 Global Nanomedicine Manufacturing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  3. 6.3 Global Nanomedicine Manufacturing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 nanoComposix
  2. 7.1.1 nanoComposix Company Information
  3. 7.1.2 nanoComposix Business Overview
  4. 7.1.3 nanoComposix Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 nanoComposix Nanomedicine Manufacturing Services Product Portfolio
  6. 7.1.5 nanoComposix Recent Developments
  7. 7.2 Ardena Nanomedicines
  8. 7.2.1 Ardena Nanomedicines Company Information
  9. 7.2.2 Ardena Nanomedicines Business Overview
  10. 7.2.3 Ardena Nanomedicines Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio
  12. 7.2.5 Ardena Nanomedicines Recent Developments
  13. 7.3 Cytiva
  14. 7.3.1 Cytiva Company Information
  15. 7.3.2 Cytiva Business Overview
  16. 7.3.3 Cytiva Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cytiva Nanomedicine Manufacturing Services Product Portfolio
  18. 7.3.5 Cytiva Recent Developments
  19. 7.4 Inside Therapeutics
  20. 7.4.1 Inside Therapeutics Company Information
  21. 7.4.2 Inside Therapeutics Business Overview
  22. 7.4.3 Inside Therapeutics Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio
  24. 7.4.5 Inside Therapeutics Recent Developments
  25. 7.5 Fortis Life Sciences
  26. 7.5.1 Fortis Life Sciences Company Information
  27. 7.5.2 Fortis Life Sciences Business Overview
  28. 7.5.3 Fortis Life Sciences Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio
  30. 7.5.5 Fortis Life Sciences Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Nanomedicine Manufacturing Services Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Ascendia Pharmaceuticals
  38. 7.7.1 Ascendia Pharmaceuticals Company Information
  39. 7.7.2 Ascendia Pharmaceuticals Business Overview
  40. 7.7.3 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio
  42. 7.7.5 Ascendia Pharmaceuticals Recent Developments
  43. 7.8 Axolabs
  44. 7.8.1 Axolabs Company Information
  45. 7.8.2 Axolabs Business Overview
  46. 7.8.3 Axolabs Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Axolabs Nanomedicine Manufacturing Services Product Portfolio
  48. 7.8.5 Axolabs Recent Developments
  49. 7.9 AVANSA Technology & Services
  50. 7.9.1 AVANSA Technology & Services Company Information
  51. 7.9.2 AVANSA Technology & Services Business Overview
  52. 7.9.3 AVANSA Technology & Services Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio
  54. 7.9.5 AVANSA Technology & Services Recent Developments
  55. 7.10 MyBiotech
  56. 7.10.1 MyBiotech Company Information
  57. 7.10.2 MyBiotech Business Overview
  58. 7.10.3 MyBiotech Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MyBiotech Nanomedicine Manufacturing Services Product Portfolio
  60. 7.10.5 MyBiotech Recent Developments
  61. 7.11 Nanochemazone
  62. 7.11.1 Nanochemazone Company Information
  63. 7.11.2 Nanochemazone Business Overview
  64. 7.11.3 Nanochemazone Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nanochemazone Nanomedicine Manufacturing Services Product Portfolio
  66. 7.11.5 Nanochemazone Recent Developments
  67. 7.12 TechNanoIndia
  68. 7.12.1 TechNanoIndia Company Information
  69. 7.12.2 TechNanoIndia Business Overview
  70. 7.12.3 TechNanoIndia Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio
  72. 7.12.5 TechNanoIndia Recent Developments
  73. 7.13 Encapsula NanoSciences
  74. 7.13.1 Encapsula NanoSciences Company Information
  75. 7.13.2 Encapsula NanoSciences Business Overview
  76. 7.13.3 Encapsula NanoSciences Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio
  78. 7.13.5 Encapsula NanoSciences Recent Developments
  79. 7.14 STA Pharmaceutical Co. Ltd.
  80. 7.14.1 STA Pharmaceutical Co. Ltd. Company Information
  81. 7.14.2 STA Pharmaceutical Co. Ltd. Business Overview
  82. 7.14.3 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio
  84. 7.14.5 STA Pharmaceutical Co. Ltd. Recent Developments
8 North America
  1. 8.1 North America Nanomedicine Manufacturing Services Revenue (2021-2032)
  2. 8.2 North America Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Nanomedicine Manufacturing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Nanomedicine Manufacturing Services Revenue by Type (2027-2032)
  5. 8.3 North America Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Nanomedicine Manufacturing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Nanomedicine Manufacturing Services Revenue by Application (2027-2032)
  9. 8.5 North America Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Nanomedicine Manufacturing Services Revenue by Country
  11. 8.6.1 North America Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nanomedicine Manufacturing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Nanomedicine Manufacturing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nanomedicine Manufacturing Services Revenue (2021-2032)
  2. 9.2 Europe Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nanomedicine Manufacturing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nanomedicine Manufacturing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nanomedicine Manufacturing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nanomedicine Manufacturing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nanomedicine Manufacturing Services Revenue by Country
  11. 9.6.1 Europe Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nanomedicine Manufacturing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nanomedicine Manufacturing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nanomedicine Manufacturing Services Revenue (2021-2032)
  2. 10.2 China Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Nanomedicine Manufacturing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Nanomedicine Manufacturing Services Revenue by Type (2027-2032)
  5. 10.3 China Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Nanomedicine Manufacturing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Nanomedicine Manufacturing Services Revenue by Application (2027-2032)
  9. 10.5 China Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nanomedicine Manufacturing Services Revenue (2021-2032)
  2. 11.2 Asia Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nanomedicine Manufacturing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nanomedicine Manufacturing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nanomedicine Manufacturing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nanomedicine Manufacturing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nanomedicine Manufacturing Services Revenue by Country
  11. 11.6.1 Asia Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nanomedicine Manufacturing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nanomedicine Manufacturing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nanomedicine Manufacturing Services Revenue (2021-2032)
  2. 12.2 SAMEA Nanomedicine Manufacturing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nanomedicine Manufacturing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nanomedicine Manufacturing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nanomedicine Manufacturing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nanomedicine Manufacturing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nanomedicine Manufacturing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nanomedicine Manufacturing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nanomedicine Manufacturing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nanomedicine Manufacturing Services Revenue by Country
  11. 12.6.1 SAMEA Nanomedicine Manufacturing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nanomedicine Manufacturing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nanomedicine Manufacturing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst